Open-mkt buys · 90d
$1.18M
4 trades · 2 insiders
Open-mkt sales · 90d
$103.1K
5 trades · 2 insiders
Net · 90d
$1.08M
Insiders on file
14
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Yu Jeffrey | Chief Medical Officer, Director, 10% Owner | 76 | $2.37M | $0 | 2026-10-09 |
| Kosasa Thomas | Director, 10% Owner | 18 | $4.90M | $0 | 2026-10-07 |
| Green Aaron | Chief Executive Officer, Director | 13 | $51.7K | $266.1K | 2026-09-24 |
| Golden Robert Lawrence | Chief Financial Officer, Director | 12 | $513 | $55.3K | 2026-09-21 |
| McCraw Sherry Coonse | Director | 2 | $0 | $0 | 2025-11-26 |
| Alleyne Kenneth | Director | 1 | $0 | $0 | 2025-11-26 |
| Casaburi Eric | Director | 9 | $39.3K | $0 | 2025-11-26 |
| Clarke Jair | Director | 3 | $0 | $0 | 2025-11-26 |
| Zeinfeld Andrew B | Director | 3 | $0 | $0 | 2025-11-26 |
| LINDSTROM RICHARD L MD | Director | 7 | $0 | $0 | 2013-06-19 |
| Hafey Chris | Other | 1 | $0 | $0 | 2013-01-08 |
| Whitney T. Blake | Director | 5 | $0 | $0 | 2013-01-08 |
| Tomlinson Percy C Jr | Director | 2 | $0 | $0 | 2013-01-08 |
| Chafoulias Gus A | Director | 8 | $0 | $0 | 2013-01-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Yu Jeffrey | Chief Medical Officer, Direc | P Buy | 2026-10-09 | 2026-10-13 | 45,126 | $5.54 | $250.0K | 896,840 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-10-07 | 2026-10-13 | 129,758 | $5.78 | $750.0K | 1,983,573 | SEC↗ |
| Green Aaron | Chief Executive Officer, Dir | S Sale | 2026-09-24 | 2026-10-09 | 1,667 | $6.48 | $10.8K | 247,971 | SEC↗ |
| Green Aaron | Chief Executive Officer, Dir | S Sale | 2026-09-22 | 2026-10-09 | 5,000 | $7.39 | $37.0K | 249,638 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer, Dir | S Sale | 2026-09-21 | 2026-10-09 | 3,000 | $6.63 | $19.9K | 91,291 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer, Dir | S Sale | 2026-09-15 | 2026-10-09 | 3,000 | $6.30 | $18.9K | 94,291 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer, Dir | S Sale | 2026-09-14 | 2026-10-09 | 2,500 | $6.60 | $16.5K | 97,291 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2026-09-10 | 2026-09-14 | 142,857 | $0.63 | $90.0K | 8,923,267 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer, Direc | P Buy | 2026-09-10 | 2026-09-14 | 142,857 | $0.63 | $90.0K | 8,923,267 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-07-30 | 2026-08-07 | 1,449,275 | $0.69 | $1000.0K | 18,538,150 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-07-30 | 2026-08-07 | 1,449,275 | $0.69 | $1000.0K | 18,538,150 | SEC↗ |
| Green Aaron | Chief Executive Officer, Dir | A Award | 2026-07-06 | 2026-10-09 | 65,000 | — | $0 | 254,638 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer, Dir | A Award | 2026-07-06 | 2026-10-09 | 35,000 | — | $0 | 99,791 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2026-06-23 | 2026-06-24 | 158,730 | $0.63 | $100.0K | 8,780,410 | SEC↗ |
| Green Aaron | Chief Executive Officer | P Buy | 2026-06-23 | 2026-06-24 | 36,650 | $0.57 | $20.9K | 1,896,375 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2026-06-16 | 2026-06-17 | 172,414 | $0.58 | $100.0K | 8,621,680 | SEC↗ |
| Green Aaron | Chief Executive Officer | P Buy | 2026-06-15 | 2026-06-16 | 18,702 | $0.54 | $10.1K | 1,859,725 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-06-12 | 2026-06-15 | 158,730 | $0.63 | $100.0K | 17,088,874 | SEC↗ |
| Green Aaron | Chief Executive Officer | P Buy | 2026-06-12 | 2026-06-16 | 36,920 | $0.56 | $20.7K | 1,841,023 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-05-18 | 2026-05-20 | 268,817 | $0.93 | $250.0K | 16,930,144 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-04-23 | 2026-04-24 | 280,898 | $0.89 | $250.0K | 16,661,327 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | A Award | 2026-04-01 | 2026-04-24 | 219,429 | $0.83 | $182.1K | 8,449,266 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2026-04-01 | 2026-04-24 | 903,614 | $0.83 | $750.0K | 8,229,837 | SEC↗ |
| Kosasa Thomas | Director, 10% Owner | P Buy | 2026-02-06 | 2026-04-24 | 595,238 | $0.84 | $500.0K | 16,380,429 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer, Dir | A Award | 2026-01-01 | 2026-10-09 | 10,000 | — | $0 | 64,791 | SEC↗ |
| McCraw Sherry Coonse | Director | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 56,342 | SEC↗ |
| Kosasa Thomas | Director | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 15,785,191 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 547,905 | SEC↗ |
| Green Aaron | Chief Executive Officer | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 1,930,425 | SEC↗ |
| Casaburi Eric | Director | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 110,475 | SEC↗ |
| Alleyne Kenneth | Director | A Award | 2025-11-26 | 2025-11-26 | 38,219 | — | $0 | 38,219 | SEC↗ |
| Zeinfeld Andrew B | Director | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 381,525 | SEC↗ |
| Clarke Jair | Director | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 138,485 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | A Award | 2025-11-26 | 2025-11-26 | 45,000 | — | $0 | 7,326,223 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2025-11-24 | 2025-11-26 | 33,333 | — | $0 | 502,905 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2025-11-24 | 2025-11-26 | 300,000 | — | $0 | 469,572 | SEC↗ |
| Green Aaron | Chief Executive Officer | A Award | 2025-11-24 | 2025-11-26 | 1,000,000 | — | $0 | 1,885,425 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | A Award | 2025-11-24 | 2025-11-26 | 200,000 | — | $0 | 7,281,223 | SEC↗ |
| Green Aaron | Chief Executive Officer | S Sale | 2025-11-18 | 2025-12-23 | 61,555 | $1.20 | $73.9K | 1,804,103 | SEC↗ |
| Green Aaron | Chief Executive Officer | S Sale | 2025-10-22 | 2025-12-23 | 64,767 | $2.23 | $144.4K | 1,865,658 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2025-10-15 | 2025-11-26 | 10,000 | $3.05 | $30.5K | 65,475 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-25 | 2025-11-26 | 1,250 | $1.03 | $1.3K | 7,081,223 | SEC↗ |
| Kosasa Thomas | Director | P Buy | 2025-09-24 | 2025-11-26 | 6,000 | $0.93 | $5.6K | 15,740,191 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-24 | 2025-11-26 | 17,200 | $1.02 | $17.5K | 7,079,973 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-23 | 2025-11-26 | 5,700 | $0.93 | $5.3K | 7,062,773 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-22 | 2025-11-26 | 400 | $0.95 | $380 | 7,057,073 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-19 | 2025-11-26 | 1,250 | $0.89 | $1.1K | 7,056,673 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-18 | 2025-11-26 | 700 | $0.91 | $637 | 7,055,423 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-05 | 2025-11-26 | 2,100 | $0.86 | $1.8K | 7,054,723 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-04 | 2025-11-26 | 11,810 | $0.87 | $10.3K | 7,052,623 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-03 | 2025-11-26 | 11,670 | $0.81 | $9.5K | 7,040,813 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-09-02 | 2025-11-26 | 24,319 | $0.85 | $20.7K | 7,029,143 | SEC↗ |
| Kosasa Thomas | Director | P Buy | 2025-08-29 | 2025-11-26 | 581,395 | $0.86 | $500.0K | 15,734,191 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-29 | 2025-11-26 | 10,890 | $0.82 | $8.9K | 7,004,824 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-28 | 2025-11-26 | 17,000 | $0.80 | $13.6K | 6,993,934 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-27 | 2025-11-26 | 21,374 | $0.69 | $14.7K | 6,976,934 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-26 | 2025-11-26 | 173,350 | $0.69 | $119.6K | 6,955,560 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-25 | 2025-11-26 | 13,300 | $0.75 | $10.0K | 6,782,210 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-21 | 2025-11-26 | 15,000 | $0.77 | $11.6K | 6,768,910 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-08-19 | 2025-11-26 | 16,500 | $0.77 | $12.7K | 6,753,910 | SEC↗ |
| Kosasa Thomas | Director | P Buy | 2025-06-20 | 2025-11-26 | 1,190,476 | $0.42 | $500.0K | 15,152,796 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2025-06-20 | 2025-11-26 | 1,666,666 | $0.42 | $700.0K | 6,737,410 | SEC↗ |
| Kosasa Thomas | Director | C Conversion | 2025-06-19 | 2025-11-26 | 2,865,016 | $0.71 | $2.03M | 13,962,320 | SEC↗ |
| Kosasa Thomas | Director | C Conversion | 2025-06-19 | 2025-11-26 | 2,123,424 | $0.75 | $1.59M | 11,097,304 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | C Conversion | 2025-06-19 | 2025-11-26 | 1,828,279 | $0.71 | $1.30M | 5,070,744 | SEC↗ |
| Kosasa Thomas | Director | C Conversion deriv | 2025-06-17 | 2025-11-26 | 493,056 | — | $0 | 0 | SEC↗ |
| Green Aaron | Chief Executive Officer | C Conversion deriv | 2025-06-17 | 2025-11-26 | 240,425 | — | $0 | 0 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | C Conversion deriv | 2025-06-17 | 2025-11-26 | 479,270 | $1.14 | $546.4K | 0 | SEC↗ |
| Kosasa Thomas | Director | C Conversion | 2025-06-17 | 2025-11-26 | 493,056 | $1.14 | $562.1K | 8,973,880 | SEC↗ |
| Green Aaron | Chief Executive Officer | C Conversion | 2025-06-17 | 2025-11-26 | 240,425 | $1.14 | $274.1K | 885,425 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | C Conversion | 2025-06-17 | 2025-11-26 | 479,270 | $1.14 | $546.4K | 3,242,465 | SEC↗ |
| Kosasa Thomas | Director | P Buy | 2025-06-16 | 2025-11-26 | 55,000 | $0.38 | $20.9K | 8,480,824 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy deriv | 2025-05-09 | 2025-11-26 | 5,946 | $0.03 | $178 | 5,946 | SEC↗ |
| Kosasa Thomas | Director | P Buy | 2025-04-21 | 2025-11-26 | 47,000 | $0.49 | $23.0K | 8,425,824 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2025-01-31 | 2025-11-26 | 24,272 | — | $0 | 169,572 | SEC↗ |
| Clarke Jair | Director | A Award | 2025-01-01 | 2025-11-26 | 82,143 | — | $0 | 93,485 | SEC↗ |
| Zeinfeld Andrew B | Director | A Award | 2025-01-01 | 2025-11-26 | 82,143 | — | $0 | 336,525 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-12-18 | 2025-11-26 | 100 | $0.99 | $99 | 2,763,195 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-11-20 | 2025-11-26 | 1,300 | $0.87 | $1.1K | 55,475 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-11-12 | 2025-11-26 | 500 | $0.85 | $425 | 54,175 | SEC↗ |
| Clarke Jair | Director | A Award | 2024-10-01 | 2025-11-26 | 11,342 | — | $0 | 11,342 | SEC↗ |
| McCraw Sherry Coonse | Director | A Award | 2024-10-01 | 2025-11-26 | 11,342 | — | $0 | 11,342 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | A Award | 2024-10-01 | 2025-11-26 | 230,769 | $0.57 | $131.5K | 2,763,095 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-09-20 | 2025-11-26 | 1,600 | $0.66 | $1.1K | 2,532,326 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-09-18 | 2025-11-26 | 800 | $0.68 | $544 | 2,530,726 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2024-08-30 | 2025-11-26 | 100,000 | — | $0 | 145,300 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-21 | 2025-11-26 | 100 | $1.22 | $122 | 2,529,926 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-16 | 2025-11-26 | 14 | $1.41 | $20 | 2,529,826 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-15 | 2025-11-26 | 10 | $1.34 | $13 | 2,529,812 | SEC↗ |
| Zeinfeld Andrew B | Director | A Award | 2024-08-14 | 2025-11-26 | 17,260 | — | $0 | 254,382 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-14 | 2025-11-26 | 13 | $1.35 | $18 | 2,529,802 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-13 | 2025-11-26 | 2,237 | $1.19 | $2.7K | 2,529,789 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-08-12 | 2025-11-26 | 913 | $1.10 | $1.0K | 2,527,552 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-07-08 | 2025-11-26 | 4,100 | $0.92 | $3.8K | 53,675 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-10 | 2025-11-26 | 1,203 | $0.52 | $626 | 2,526,639 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-08 | 2025-11-26 | 105 | $0.69 | $72 | 2,525,436 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-07 | 2025-11-26 | 106 | $0.68 | $72 | 2,525,331 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-06 | 2025-11-26 | 214 | $0.65 | $139 | 2,525,225 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-03 | 2025-11-26 | 350 | $0.60 | $210 | 2,525,011 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-05-02 | 2025-11-26 | 100 | $0.62 | $62 | 2,524,661 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-04-24 | 2025-11-26 | 100 | $0.65 | $65 | 2,524,561 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-03-22 | 2025-11-26 | 100 | $0.79 | $79 | 2,524,461 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-03-06 | 2025-11-26 | 16 | $0.84 | $13 | 2,524,361 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-03-05 | 2025-11-26 | 2,000 | $0.74 | $1.5K | 49,575 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-02-29 | 2025-11-26 | 575 | $0.72 | $414 | 47,575 | SEC↗ |
| Casaburi Eric | Director | P Buy | 2024-02-16 | 2025-11-26 | 2,000 | $0.77 | $1.5K | 47,000 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-02-16 | 2025-11-26 | 100 | $0.82 | $82 | 2,524,345 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-02-08 | 2025-11-26 | 2 | $1.19 | $2 | 2,524,245 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-02-01 | 2025-11-26 | 1,357 | $1.45 | $2.0K | 2,524,243 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-30 | 2025-11-26 | 400 | $1.14 | $456 | 2,522,886 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-29 | 2025-11-26 | 950 | $1.04 | $988 | 2,522,486 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-26 | 2025-11-26 | 5,386 | $0.56 | $3.0K | 2,521,536 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-25 | 2025-11-26 | 2,304 | $0.55 | $1.3K | 2,516,150 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-24 | 2025-11-26 | 740 | $0.55 | $407 | 2,513,846 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-23 | 2025-11-26 | 720 | $0.52 | $374 | 2,513,106 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-22 | 2025-11-26 | 5,035 | $0.49 | $2.5K | 2,512,386 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | A Award | 2024-01-19 | 2025-11-26 | 45,000 | — | $0 | 2,507,351 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-19 | 2025-11-26 | 60 | $0.48 | $29 | 2,462,351 | SEC↗ |
| Kosasa Thomas | Director | A Award | 2024-01-19 | 2025-11-26 | 45,000 | — | $0 | 8,378,824 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | A Award | 2024-01-19 | 2025-11-26 | 45,000 | — | $0 | 45,300 | SEC↗ |
| Green Aaron | Chief Executive Officer | A Award | 2024-01-19 | 2025-11-26 | 45,000 | — | $0 | 645,000 | SEC↗ |
| Casaburi Eric | Director | A Award | 2024-01-19 | 2025-11-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-17 | 2025-11-26 | 362 | $0.61 | $221 | 2,462,291 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-16 | 2025-11-26 | 15 | $0.75 | $11 | 2,461,929 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-12 | 2025-11-26 | 20 | $0.81 | $16 | 2,461,914 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-10 | 2025-11-26 | 20 | $0.85 | $17 | 2,461,894 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-09 | 2025-11-26 | 100 | $0.86 | $86 | 2,461,874 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-08 | 2025-11-26 | 10 | $0.83 | $8 | 2,461,774 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-04 | 2025-11-26 | 180 | $0.84 | $151 | 2,461,764 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2024-01-02 | 2025-11-26 | 20 | $0.82 | $16 | 2,461,584 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-27 | 2025-11-26 | 10 | $1.03 | $10 | 2,461,564 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-15 | 2025-11-26 | 10 | $0.92 | $9 | 2,461,554 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-13 | 2025-11-26 | 50 | $1.09 | $55 | 2,461,544 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-12 | 2025-11-26 | 3,040 | $1.06 | $3.2K | 2,461,494 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-11 | 2025-11-26 | 30 | $1.36 | $41 | 2,458,454 | SEC↗ |
| Yu Jeffrey | Chief Medical Officer | P Buy | 2023-12-08 | 2025-11-26 | 3,300 | $1.31 | $4.3K | 2,458,424 | SEC↗ |
| Golden Robert Lawrence | Chief Financial Officer | P Buy | 2023-12-07 | 2025-11-26 | 300 | $1.71 | $513 | 300 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | P Buy deriv | 2013-06-19 | 2013-06-20 | 0 | — | $0 | 0 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | P Buy deriv | 2013-06-19 | 2013-06-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2013-01-08 | 2013-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Whitney T. Blake | Director | A Award deriv | 2013-01-08 | 2013-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Chafoulias Gus A | Director | A Award deriv | 2013-01-08 | 2013-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Tomlinson Percy C Jr | Director | A Award deriv | 2013-01-08 | 2013-01-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Hafey Chris | Other | A Award deriv | 2013-01-08 | 2013-01-10 | 50,000 | — | $0 | 20,000 | SEC↗ |
| Chafoulias Gus A | Director | P Buy deriv | 2012-12-31 | 2013-01-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chafoulias Gus A | Director | P Buy deriv | 2012-12-31 | 2013-01-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Whitney T. Blake | Director | J Other | 2012-09-28 | 2012-10-04 | 66,732 | $0.25 | $16.7K | 66,732 | SEC↗ |
| Chafoulias Gus A | Director | J Other | 2012-09-28 | 2012-10-04 | 111,219 | $0.25 | $27.8K | 981,219 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | J Other | 2012-09-28 | 2012-10-04 | 884,066 | $0.25 | $221.0K | 884,066 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | J Other | 2012-09-28 | 2012-10-04 | 884,066 | $0.25 | $221.0K | 73,496 | SEC↗ |
| Chafoulias Gus A | Director | A Award deriv | 2012-04-26 | 2012-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | A Award deriv | 2012-04-26 | 2012-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Tomlinson Percy C Jr | Director | A Award deriv | 2012-04-26 | 2012-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Whitney T. Blake | Director | A Award deriv | 2012-04-26 | 2012-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Chafoulias Gus A | Director | P Buy deriv | 2011-12-30 | 2012-01-04 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Whitney T. Blake | Director | P Buy deriv | 2011-12-30 | 2012-01-04 | 22,500 | — | $0 | 22,500 | SEC↗ |
| LINDSTROM RICHARD L MD | Director | P Buy deriv | 2011-12-30 | 2012-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chafoulias Gus A | Director | P Buy deriv | 2011-11-17 | 2012-02-02 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Chafoulias Gus A | Director | P Buy | 2011-11-17 | 2012-02-02 | 10,000 | — | $0 | 870,000 | SEC↗ |
| Whitney T. Blake | Director | A Award deriv | 2011-04-26 | 2012-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |